MENTAL HEALTH IMPLEMENTATION & INNOVATION SEMINAR
With the aims of inspiring, informing, and engaging participants regarding ‘Depression & Anxiety’ and ‘Dementia’ outcomes measurement, this seminar will bring together implementers and early adopters to discuss the implementation journey, share lessons learned, innovative practice, how to tie outcomes measurement into organizational strategy and generate interest for benchmarking.
Dr Alethse de la Torre
Standardization Project Leader
Prof David Clark
Professor and Chair of Experimental Psychology, Oxford University
Chair of the Mental Health Information Network
Working Group Member of the Depression and Anxiety Standard Set
Mr Wayne Goddard
Former Head of Strategy and Delivery &Integrated Lead for Dementia
NHS Doncaster CCG and DMBC
Implementing the Dementia Standard Set
Dr Rishi Hazarika
Vice President, Global Implementation and Courses,
Ms Francine Jury
Clinical Project Manager – Project CYGNUS, The University of Manchester
Implementing the Dementia Standard Set and Research Applications
Ms Léa Marais
Implementation Project Leader & TechHub Lead,
Dr Shehzad Niazi
Psychiatrist, Mayo Clinic
Implementing the Depression and Anxiety Standard Set
Mr Urban Pettersson Bargo
CEO, WeMind Psychiatry
Dr Andrea Srur
Implementation Project Leader, ICHOM
Prof David Clark
David M Clark is the Professor of Experimental Psychology at the University of Oxford. He is well–known for his pioneering work in combining experimental psychopathology and clinical studies to develop new and effective psychological treatments for anxiety disorders. NICE currently recommends the treatments developed by David’s group as first line interventions for panic disorder, social anxiety disorder and PTSD. In recent years, he has also focused on how to effectively disseminate treatments to the public and is one of the architects of the English Improving Access to Psychological Therapies (IAPT) Programme. He is an Honorary Fellow of the BPS & BABCP and a Fellow of the British Academy and Academy of Medical Sciences. He holds Lifetime Achievement/Distinguished Scientist Awards from BPS, American Psychological Association, American Association for Behavioural and Cognitive Therapies and the Society for Science in Clinical Psychology.
Dr Alethse de la Torre
Standardization Project Leader
Alethse joined ICHOM in late 2016 as a Project Leader on Standardization team. Prior to joining ICHOM, she worked as an infectious diseases consultant in Latin-America and on programmes to improve the quality and safety of patient care. Alethse is a Patients for Patient Safety Champion- Mexico. Alethse received her medical degrees from the UNAM, Mexico and a Master of Public Health in Developing Countries from the London School of Hygiene and Tropical Medicine.
Wayne has worked for the NHS for 33 years commencing General Nurse training in 1984 and then Mental Health training in 1989. He has worked clinically with all age groups in Ward and Service management. Wayne became specifically interested in dementia when he was a Ward Manager of a Dementia Assessment Ward and took this interest into commissioning when he became the Assistant Director for Commissioning in Doncaster.
Rishi leads ICHOM’s implementation and courses work globally. Rishi originally trained as a surgeon and prior to ICHOM worked at Monitor, the economic regulator for the NHS, where he was responsible for the turnaround and restructuring of hospitals in financial and quality difficulties. He has a background of working in provider organisations in senior roles including the Associate Medical Director for Strategy at Birmingham Children’s Hospital, one of four specialist children’s hospitals in England. Rishi has trained in health policy at Imperial College London and studied at Harvard, INSEAD and London Business School.
Francine is the operations manager for the Clinical Dementia Research Group at the University of Manchester and leads on a programme of research on digital brain health. She has a scientific background in Molecular Genetics and Epidemiology and an interest in the improvement of public understanding of, and access to clinical research. She sits on the steering committee for the National Institute of Health Research Patient Research Ambassador Initiative, and has worked across academic and NHS settings in the delivery of clinical research.
Léa joined ICHOM in November 2016 as a Project Leader for the Implementation team and is based in the London office. Prior to joining ICHOM, Léa worked as a research assistant at the neuroimaging platform of the Brain and Spinal Cord Institute in Paris and moved to the industry where she has been working as programme manager in the field of dementia research, from clinical trials (pharmaceuticals and medical device), to designing and deploying digital technologies aimed to support patients/carers in their homes and collect data in a real-world setting. Léa has a background in medical imaging and holds a Master in electronics and computer science as well as a Bachelor in Psychology.
Dr Shehzad Niazi
Dr. Niazi is a consultant in Department of Psychiatry Mayo Clinic Florida and Assistant Professor of Psychiatry at Mayo Medical School. He primarily works with Cancer and Transplant Centers. He is board certified by the American Board of Psychiatry and Neurology in Psychiatry and in Psychosomatic Medicine. He has Specialty Certificate in Psychiatry from the Royal College of Physicians and surgeons of Canada and is a Fellow of Royal College of Physicians and Surgeons of Canada. He is also a Distinguished Fellow of the American Psychiatric Association and a fellow of the Academy of Psychosomatic Medicine. He has been working with Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery conducting Health Services Research. He is interested in clinical-informatics, healthcare delivery models, implementing patient reported outcomes and understanding impact of psychiatric conditions on economic, clinical and humanistic outcomes in cancer and transplant patients.
Urban Pettersson Bargo
Urban decided 15 years ago that he wanted to improve the quality of mental health care in Sweden. After studying psychology, he founded WeMind with a focus of providing evidenced based mental health care and to measure the outcome for every single patient. WeMind were one of the first organisations in the world to fully implement the ICHOM standard set for anxiety and depression and he is committed to work for an implementation of a global standard for outcome measurement in mental health care.
Urban holds a Master in Business Administration from Stockholm School of Economics and in his prior career he worked for Procter & Gamble and as an entrepreneur within the IT industry in Sweden and the US.
Andrea is a Medical Doctor trained in Chile. Following her training, she completed a MSc in Management and Organisational Innovation at Queen Mary University London. Through her experiences as Head of the Non-Communicable Diseases Department at the Ministry of Health in Chile, she developed an interest for Value-Based health care and joins ICHOM as an Implementation Project Leader in 2016. She is currently completing a MSc in Health Systems and Global Policies at Queen Mary University London.
- The process that defines the outcomes that matter
- The Mental Health Standard Set and outcomes measures
- ICHOM’s Standard Set implementation framework
- The Value Based Health Care reconfiguration of hospital activities and strategy at WeMind
- WeMind’s Implementation Journey
- Implementing the Dementia Standard Set: NHS Doncaster
- Implementing the Depression and Anxiety Standard Set: Mayo Clinic
- The impact of outcomes measurement on hospital operations and strategy
- Why benchmarking is an effective tool to share information across hospitals and to improve outcomes for patients
- The Benchmarking programme
- The structure of the Value Innovation Community for Mental Health
- How the hospitals in the Value Innovation Community can learn from each other using the data from the Benchmarking programme
About WEMIND PSYCHIATRY
WeMind is a privately-owned chain of mental health clinics in Stockholm and Gothenburg, Sweden. The chain comprises 3 clinics and 1 care home, serving 2,500 patients per year. These patients are referred from the public health system with a diagnosis of severe depression or anxiety disorder.
WeMind aims to be a mental health provider that places routine patient-centred outcomes measurement at the very core of its operational model, improving mental health for their patients.
Since inception, WeMind have been using patient-centred outcomes measurement as the basis for guiding the selection and evaluation of interventions and monitoring of patient progress. The core dataset on which their outcomes measurement efforts are based is the ICHOM Standard Set for Anxiety and Depression, which WeMind implemented in early 2016.